Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
基本信息
- 批准号:8244524
- 负责人:
- 金额:$ 37.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-15 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimalsAntioxidantsBasic ScienceBindingBiological ModelsCardiovascular DiseasesChemicalsCysteineDevelopmentDiquatDiseaseDrug or chemical Tissue DistributionEmbryoEmbryonic DevelopmentEnvironmental ExposureFamilyFishesFoundationsGene ExpressionGenerationsGenesGenetic TranscriptionGenomicsGlutamate-Cysteine LigaseGlutathioneGlutathione S-TransferaseGrowthHomologous GeneHumanIndividualLifeLigaseLinkMammalsMediatingModelingMolecularNAD(P)H dehydrogenase (quinone) 1, humanNF-E2-related factor 2NQO1 geneNeurodegenerative DisordersOligonucleotidesOxidantsOxidative StressPhenotypePredispositionProductionProtein BiosynthesisProtein FamilyProtein IsoformsProteinsReactive Oxygen SpeciesRegulationRegulatory ElementReporter GenesResearchResponse ElementsReverse Transcriptase Polymerase Chain ReactionRisk AssessmentRoleScreening procedureStagingSulforaphaneSuperoxide DismutaseTestingTimeToxic effectTransgenesTransgenic OrganismsZebrafishabstractingbZIP Domainbiological adaptation to stressexperimental analysishuman diseasein vivoinsightknock-downmature animalmemberparalogous genepromoterpublic health relevanceresearch studyresponsetooltoxicant
项目摘要
Project Summary/Abstract
Oxidative stress resulting from environmental exposures is associated with a variety of human diseases
ranging from chemical teratogenesis to cardiovascular and neurodegenerative diseases. Developing animals
appear to be especially sensitive to chemicals causing oxidative stress. The expression and inducibility of anti-
oxidant defenses are critical factors affecting susceptibility to oxidants at these early life stages, but the
ontogenic development of these responses in embryos is not well understood. In adult animals, oxidants
initiate an anti-oxidant response by activating NF-E2-related factor 2 (NRF2) and related proteins, which bind
to the anti-oxidant response element and activate transcription of genes such as glutathione S-transferases,
NAD(P)H-quinone oxidoreductase, glutamyl-cysteine ligase, and superoxide dismutase. The overall objective
of the research proposed here is to elucidate the mechanisms by which vertebrate embryos respond to
oxidative stress during development. We will test the central hypothesis that responsiveness to oxidative stress
and the set of regulated genes vary during development. Because of these developmental differences, some
stages may be more sensitive to oxidative stress-induced damage. These studies will be performed in vivo
using embryos of the zebrafish (Danio rerio), a valuable model in which to examine mechanisms of toxicity in
developing animals and to screen chemicals for developmental toxicity.
Aim 1 will use transcriptional profiling and phenotypic anchoring to identify the core set of genes that
comprise the oxidative stress response in embryos, establish how the responsiveness and composition of the
core set of oxidant-responsive genes vary with developmental stage of embryos, and determine how the timing
and gene profile of the oxidative stress response differ in embryos exposed to structurally and mechanistically
distinct activators of NRF2 (tBHQ, diquat, sulforaphane). Aim 2 will elucidate the roles of different NRF
paralogs in the transcriptional response to oxidative stress during development in embryos in vivo, using
targeted knock-down of NRF protein synthesis with morpholino oligonucleotides. Aim 3 will establish the
mechanism of regulation of anti-oxidant response genes during embryonic development through computational
and in vivo experimental analysis of oxidant-responsive gene promoters, leading to the generation of a stable
line of transgenic zebrafish expressing a reporter gene (GFP) in response to oxidative stress. Finally, we will
test a set of mammalian developmental toxicants for the ability to activate the transgene in embryos.
The results of these studies will establish the composition and ontogeny of the transcriptional response to
oxidative stress in vertebrate embryos, elucidate fundamental mechanisms underlying this response, generate
tools for screening chemicals for activity as developmental toxicants or antioxidants, and provide insight into
the role of oxidative stress in human disease.
项目概要/摘要
环境暴露引起的氧化应激与多种人类疾病有关
从化学致畸到心血管和神经退行性疾病。发育中的动物
似乎对引起氧化应激的化学物质特别敏感。抗-的表达和诱导
氧化防御是影响生命早期阶段对氧化剂敏感性的关键因素,但
胚胎中这些反应的个体发育尚不清楚。在成年动物中,氧化剂
通过激活 NF-E2 相关因子 2 (NRF2) 和相关蛋白来启动抗氧化反应,这些蛋白与
抗氧化反应元件并激活谷胱甘肽 S-转移酶等基因的转录,
NAD(P)H-醌氧化还原酶、谷氨酰半胱氨酸连接酶和超氧化物歧化酶。总体目标
这里提出的研究的目的是阐明脊椎动物胚胎对
发育过程中的氧化应激。我们将测试中心假设,即对氧化应激的反应
并且受调控的基因组在发育过程中会发生变化。由于这些发育差异,一些
阶段可能对氧化应激引起的损伤更敏感。这些研究将在体内进行
使用斑马鱼(Danio rerio)的胚胎,这是一个有价值的模型,可用于检查斑马鱼的毒性机制
发育中的动物并筛选化学品的发育毒性。
目标 1 将使用转录分析和表型锚定来识别核心基因集
包括胚胎中的氧化应激反应,确定氧化应激反应的反应性和组成如何
氧化反应基因的核心组随胚胎发育阶段的不同而变化,并决定了其发生的时间
暴露于结构和机制的胚胎中氧化应激反应的基因谱和基因谱有所不同
NRF2 的不同激活剂(tBHQ、敌草快、萝卜硫素)。目标 2 将阐明不同 NRF 的作用
使用旁系同源物在体内胚胎发育过程中对氧化应激的转录反应
使用吗啉代寡核苷酸靶向抑制 NRF 蛋白质合成。目标 3 将建立
通过计算调节胚胎发育过程中抗氧化反应基因的机制
以及氧化反应基因启动子的体内实验分析,从而产生稳定的
表达报告基因(GFP)以应对氧化应激的转基因斑马鱼品系。最后,我们将
测试一组哺乳动物发育毒物激活胚胎中转基因的能力。
这些研究的结果将确定转录反应的组成和个体发育
脊椎动物胚胎中的氧化应激,阐明这种反应的基本机制,产生
用于筛选化学物质作为发育毒物或抗氧化剂的活性的工具,并提供深入了解
氧化应激在人类疾病中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark E Hahn其他文献
Mark E Hahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark E Hahn', 18)}}的其他基金
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
- 批准号:
10679532 - 财政年份:2023
- 资助金额:
$ 37.08万 - 项目类别:
Mechanisms Controlling Sensitivity and Resistance to Dioxin-like Compounds: Role of AIP
控制对二恶英类化合物的敏感性和耐受性的机制:AIP 的作用
- 批准号:
10538943 - 财政年份:2022
- 资助金额:
$ 37.08万 - 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:
10216463 - 财政年份:2021
- 资助金额:
$ 37.08万 - 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:
10655611 - 财政年份:2021
- 资助金额:
$ 37.08万 - 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:
10434783 - 财政年份:2018
- 资助金额:
$ 37.08万 - 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:
10223309 - 财政年份:2018
- 资助金额:
$ 37.08万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
8051862 - 财政年份:2009
- 资助金额:
$ 37.08万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
8450175 - 财政年份:2009
- 资助金额:
$ 37.08万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
7655110 - 财政年份:2009
- 资助金额:
$ 37.08万 - 项目类别:
相似国自然基金
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
- 批准号:
10643012 - 财政年份:2023
- 资助金额:
$ 37.08万 - 项目类别:
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:
10584938 - 财政年份:2023
- 资助金额:
$ 37.08万 - 项目类别:
Dual-Wavelength Blue Light Irradiation for Improved Treatment of Staphylococcus aureus Infections
双波长蓝光照射改善金黄色葡萄球菌感染的治疗
- 批准号:
10724476 - 财政年份:2023
- 资助金额:
$ 37.08万 - 项目类别: